_version_ 1785131629255065600
author Roberts, Holly J.
Ji, Sunjong
Picca, Alberto
Sanson, Marc
Garcia, Mekka
Snuderl, Matija
Schüller, Ulrich
Picart, Thiébaud
Ducray, François
Green, Adam L.
Nakano, Yoshiko
Sturm, Dominik
Abdullaev, Zied
Aldape, Kenneth
Dang, Derek
Kumar-Sinha, Chandan
Wu, Yi-Mi
Robinson, Dan
Vo, Josh N.
Chinnaiyan, Arul M.
Cartaxo, Rodrigo
Upadhyaya, Santhosh A.
Mody, Rajen
Chiang, Jason
Baker, Suzanne
Solomon, David
Venneti, Sriram
Pratt, Drew
Waszak, Sebastian M.
Koschmann, Carl
author_facet Roberts, Holly J.
Ji, Sunjong
Picca, Alberto
Sanson, Marc
Garcia, Mekka
Snuderl, Matija
Schüller, Ulrich
Picart, Thiébaud
Ducray, François
Green, Adam L.
Nakano, Yoshiko
Sturm, Dominik
Abdullaev, Zied
Aldape, Kenneth
Dang, Derek
Kumar-Sinha, Chandan
Wu, Yi-Mi
Robinson, Dan
Vo, Josh N.
Chinnaiyan, Arul M.
Cartaxo, Rodrigo
Upadhyaya, Santhosh A.
Mody, Rajen
Chiang, Jason
Baker, Suzanne
Solomon, David
Venneti, Sriram
Pratt, Drew
Waszak, Sebastian M.
Koschmann, Carl
author_sort Roberts, Holly J.
collection PubMed
description
format Online
Article
Text
id pubmed-10627895
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-106278952023-11-08 Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations Roberts, Holly J. Ji, Sunjong Picca, Alberto Sanson, Marc Garcia, Mekka Snuderl, Matija Schüller, Ulrich Picart, Thiébaud Ducray, François Green, Adam L. Nakano, Yoshiko Sturm, Dominik Abdullaev, Zied Aldape, Kenneth Dang, Derek Kumar-Sinha, Chandan Wu, Yi-Mi Robinson, Dan Vo, Josh N. Chinnaiyan, Arul M. Cartaxo, Rodrigo Upadhyaya, Santhosh A. Mody, Rajen Chiang, Jason Baker, Suzanne Solomon, David Venneti, Sriram Pratt, Drew Waszak, Sebastian M. Koschmann, Carl Acta Neuropathol Correspondence Springer Berlin Heidelberg 2023-10-18 2023 /pmc/articles/PMC10627895/ /pubmed/37851269 http://dx.doi.org/10.1007/s00401-023-02640-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Roberts, Holly J.
Ji, Sunjong
Picca, Alberto
Sanson, Marc
Garcia, Mekka
Snuderl, Matija
Schüller, Ulrich
Picart, Thiébaud
Ducray, François
Green, Adam L.
Nakano, Yoshiko
Sturm, Dominik
Abdullaev, Zied
Aldape, Kenneth
Dang, Derek
Kumar-Sinha, Chandan
Wu, Yi-Mi
Robinson, Dan
Vo, Josh N.
Chinnaiyan, Arul M.
Cartaxo, Rodrigo
Upadhyaya, Santhosh A.
Mody, Rajen
Chiang, Jason
Baker, Suzanne
Solomon, David
Venneti, Sriram
Pratt, Drew
Waszak, Sebastian M.
Koschmann, Carl
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
title Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
title_full Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
title_fullStr Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
title_full_unstemmed Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
title_short Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
title_sort clinical, genomic, and epigenomic analyses of h3k27m-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with mapk pathway alterations
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627895/
https://www.ncbi.nlm.nih.gov/pubmed/37851269
http://dx.doi.org/10.1007/s00401-023-02640-7
work_keys_str_mv AT robertshollyj clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT jisunjong clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT piccaalberto clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT sansonmarc clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT garciamekka clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT snuderlmatija clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT schullerulrich clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT picartthiebaud clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT ducrayfrancois clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT greenadaml clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT nakanoyoshiko clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT sturmdominik clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT abdullaevzied clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT aldapekenneth clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT dangderek clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT kumarsinhachandan clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT wuyimi clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT robinsondan clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT vojoshn clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT chinnaiyanarulm clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT cartaxorodrigo clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT upadhyayasanthosha clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT modyrajen clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT chiangjason clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT bakersuzanne clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT solomondavid clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT vennetisriram clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT prattdrew clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT waszaksebastianm clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations
AT koschmanncarl clinicalgenomicandepigenomicanalysesofh3k27mmutantdiffusemidlinegliomalongtermsurvivorsrevealadistinctgroupoftumorswithmapkpathwayalterations